Regulation of Heregulinβ1-induced differentiation in a human breast carcinoma cell line by the extracellular-regulated kinase (ERK) pathway

Journal of Cellular Biochemistry

Volumn 70, Issue 4, 1998, Pages 587-595

  Lessor, Tracy ^a,b   Yoo, Joo Yeon ^a,b   Davis, Myrtle ^a   Hamburger, Anne W ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

Breast carcinoma; ERK pathway

Indexed keywords

NEU DIFFERENTIATION FACTOR; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CARRIER PROTEIN; ENZYME INHIBITOR; FLAVONOID; GLYCOPROTEIN; HEREGULIN BETA1; PROTEIN KINASE (CALCIUM,CALMODULIN);

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; GROWTH REGULATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; BREAST TUMOR; CELL CULTURE; DRUG EFFECT; ENZYMOLOGY; HUMAN; KINETICS; METABOLISM; PATHOLOGY; PHENOTYPE; PHYSIOLOGY;

BREAST NEOPLASMS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARRIER PROTEINS; CELL DIFFERENTIATION; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; GLYCOPROTEINS; HUMANS; KINETICS; NEUREGULIN-1; PHENOTYPE; TUMOR CELLS, CULTURED;

EID: 0032529849     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980915)70:4<587::AID-JCB14>3.0.CO;2-E     Document Type: Article

References (52)

1. Aicher A, Westermann J, Cayeus S, Willinsky G, Daemen K, Blankenstein T, Uckert W, Dorken B, Pezzuto A (1997): Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells. Exp Hematol 25: 39-44.
2. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR (1995): PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494.
3. Bacus SS, Gudkov AV, Zelnick CR, Chin D, Stern R, Stancovski I, Peles E, Ben Baruch N, Farbstein H, Lupu R, Wen D, Sela M, Yarden Y (1993): Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule I. Cancer Res 53:5251-5261.
4. Bacus SS, Huberman E, Chin D, Kiguchi K, Simpson S, Lippman M, Lupu R (1992): A ligand for the erbB2 oncogene product (gp30) induces differentiation of human breast cancer cells. Cell Growth Diff 3:401-411.
5. Bargmann CI, Hung M-C, Weinberg RA (1986): The neu oncogene encodes an epidermal growth factor receptor. Nature 319:226-230.
6. Carraway III KL, Sliwkowski MX, Akita R, Platko JV, Guy PM, Nuijens A, Diamonti AJ, Vandlen RL, Cantley LC, Cerione RA (1994): The erbB3 gene product is a receptor for heregulin. J Biol Chem 269:14303-14306.
7. Chen J, Martin BL, Brautigan DL (1992): Regulation of protein serine-threonine phosphatase 2Aby tyrosine phosphorylation. Science 257:1261-1264.
8. Davis RJ (1993): The mitogen-acitvated protein kinase signal transduction pathway. J Biol Chem 268:14553-14556.
9. Elledge RM (1992): Prognostic factors in breast cancer. Semin Oncol 19:244-253.
10. Fiore RS, Bayer VE, Pelech SL, Posada J, Cooper JA, Baraban JM (1993): p42 mitogen-activated protein kinase in brain: prominent localization in neuronal cell bodies and dendrites. Neuroscience 55:463-472.
11. Gille H, Sharrocks AD, Shaw PE (1992): Phosphorylation of transcription factor p62TCF by MAP kinase. Nature 358: 414-417.
12. Gotoh Y, Nishida E, Matsuda S, Shiina N, Kosako H, Shiokawa K, Akiyama T, Ohta K, Sakai, H (1991): In vitro effects on microtubule dynamics of purified Xenopus M phase-activated MAP kinase. Nature 349:251-254.
13. Gullick WJ (1991): Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 47:87-98.
14. Haycock JW, Ahn NG, Cobb MH, Krebs EG (1992): ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at ser-31 in situ. Proc Natl Acad Sci USA 89:2365-2369.
15. Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD, Shepard HM, Kuang W-J, Wood WI, Goedeel DV, Vandlen RL (1992): Identification of heregulin, a specific activator of p185erbB2. Science 256:1205-1210.
16. Jones FE, Jerry DJ, Guarino BC, Andrews GC, Stern DF (1996): Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli. Cell Growth Diff 7:1031-1038.
17. Kortenjann M, Thomae O, Shaw PE (1994): Inhibition of v-raf dependent c-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase ERK2. Mol Cell Biol 14:4815-4824.
18. Kraus MH, Issing M, Popescu NC, Aaronson SA (1989): Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci USA 86:9193-9197.
19. Lemoin NR, Barnes DM, Hollywood DP, Hughes CM, Smith P, Dublin W, Prigent SA, Gullick WJ, Hurst HC (1992): Expression of ERBB3 gene product in breast cancer. Br J Cancer 66:1116-1121.
20. Lewis GD, Lofgren JA, McMurtrey AE, Nuijens A, Fendly BM, Bauer KD, Sliwkowski MX (1996): Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of erbB2 as a critical component in mediating heregulin responsiveness. Cancer Res 54:1457-1465.
21. Lin L-L, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ (1993): cPLA2 is phosphorylated and activated by MAP kinase. Cell 72:269-278.
22. Mansour SJ, Mattern WT, Hermann AS, Candia JM, Rong K, Fukasawa F, Vande Woude GF, Ahn NG (1994): Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265:966-970.
23. Marshall C (1995): Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
24. Marshall CJ (1994): MAP kinase kinase kinase, MAP kinase kinase, and MAP kinase. Curr Opin Genet Dev 4:82-89.
25. Marte BM, Graus-Porta D, Jeschke M, Fabbro D, Hynes NE, Taverna D (1995): NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of HC11 mammary epithelial cells. Oncogene 10:167-175.
26. Misra-Press A, Rim CS, Yao H, Roberson MS, Stork PJS (1995): A novel mitogen-activated protein kinase phosphatase. Structure, expression, and regulation. J Biol Chem 270:14587-14596.
27. O'Neill EM, Regay I, Tjian R, Rubin GM (1994): The activities of two Ets-related transcription factors required for Drosophila eye development are modulated by the Ras/MAPK pathway. Cell 78:137-147.
28. Pang L, Sawada T, Decker SJ, Saltiel AR (1995): Inhibition of MAP kinase kinase blocks the differentiation of PC 12 cells induced by nerve growth factor. J Biol Chem 270: 13585-13588.
29. Peles E, Bacus S, Koski R, Lu H, Wen D, Ogden S, Ben Levy R, Yarden Y (1992): Isolation of the Neu/HER-2 stimulatory ligand: a 44kd glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell 69:205-216.
30. erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA 90:1746-1750.
31. Plowman GD, Culoscou J, Whitney G, Greene J, Carlton G, Foy L, Neubauer M, Shoyab M (1990): Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc Natl Acad Sci USA 87:4905-4909.
32. crbB4. Nature 366:465-473.
33. Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR (1991): Phosphorylation of c-jun mediated by MAP kinases. Nature 353:670-674.
34. Pumiglia KM, Decker SJ (1997): Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 94:448-452.
35. Sainsbury JR, Farndon JR, Needham GK, Maludm AJ, Harris AL (1987): Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1:1398-1402.
36. Seger R, Krebs EG (1995): The MAPK signaling cascade. Faseb J 9:726-735.
37. Seth A, Alvarez E, Gupta S, Davis RJ (1991): A phosphorylation site located in the NH2-terminal domain of c-myc increases transactivation of gene expression. J Biol Chem 266:23521-23524.
38. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987): Human breast cancer: Correlation of relapse and survival with amplification of the HER2/neu oncogene. Science 235:177-182.
39. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF (1989): Studies of the HER2/neu protooncogene in human breast and ovarian cancer. Science 244:707-712.
40. Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrik VD, Fendly BM, Cerione RA, Vandlen RL, Carraway III KL (1994): Coexpression of erbB2 and erbBS proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 269:14661-14665.
41. Sontag E, Nunbhakdi-Craig V, Bloom GS, Mumby MC (1995): A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle. J Cell Biol 128:1131-1144.
42. Sturgill TW, Ray LB, Erikson E, Maller JL (1988): Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 334:715-718.
43. Sun H, Charles CH, Lau LF, Tonks NK (1993): MKP-1 (3CH134) an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75:487-493.
44. Towatari M, May GE, Marias R, Perkins GR, Marshall CJ, Cowley S, Enver T (1995): Regulation of GATA-2 phosphorylation by mitogen-activated protein kinase and interleukin-3. J Biol Chem 270:4101-4107.
45. Traverse S, Gomez N, Paterson H, Marshall C, Cohen P (1992): Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem J 288:351-355.
46. Traverse S, Seedorf K, Paterson H, Marshall CJ, Cohen P, Ullrich A (1994): EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr Biol 4:694-701.
47. Tzahar E, Levkowitz G, Karungaran D, Yi L, Peles E, Lavi S, Chang D, Liu N, Yayon A, Wen D, Yarden Y (1994): ErbB3 and erbB4 function as the respective low and high affinity receptors of all neu differentiation factor/heregulin isoforms. J Biol Chem 269:25226-25233.
48. Ullrich A (1984): Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309:418-425.
49. Waskiewicz AJ, Cooper JA (1995): Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr Opin Cell Biol 7:798-805.
50. Wen D, Suggs SV, Karunagaran D, Liu N, Cupples RL, Lou Y, Janssen AM, Ben-Baruch N, Trollinger DB, Jacobsen VL, meng S-Y, Lu HS, Hu S, Chang D, Yang W, Yanigahara D, Koshi RA, Yarden Y (1994): Structural and functional aspects of the multiplicity of neu differentiation factors. Mol Cell Biol 14:1909-1919.
51. Yamamoto T, Ikawa S, Akiyami T, Semba K, Nomura N, Miyajima N, Saito T, Toyosjima K (1986): Similarity of protein encoded by the human c-erbB2 gene to epidermal growth factor receptor. Nature 319:230-234.
52. Yang Y, Spitzer E, Meyer D, Sachs M, Niemann C, Hartmann G, Weidner KM, Birchmeier C, Birchmeier W (1995): Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol 131:215-226.